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Introduction
Acute liver failure is a fatal syndrome attributed to mas-
sive hepatocyte apoptosis that is resistant to conventional
medical therapies. Consequently, liver transplantation is
required in many cases. An experimental liver failure
model induced by galactosamine (Gal) and lipopolysac-
charide (LPS) mimics clinical acute liver failure. In this
model, LPS stimulates macrophages to release TNFa,
which induces apoptosis in Gal-sensitized hepatocytes,
causing acute liver failure. Hydrogen sulphide (H2S),
which is an endogenously produced gaseous signaling
molecule, has anti-apoptotic as well as anti-inflammatory
properties. Previously, we reported that H2S attenuates
liver dysfunction arising from LPS-induced systemic
inflammation [1]. It has also been reported that H2S
reduces hepatic ischemia/reperfusion injury by inhibition
of apoptosis in the liver [2]. However, it is still unknown
whether H2S exerts hepatoprotective effects against acute
liver failure, in which both inflammatory responses and
apoptosis have critical roles. Here, we examined the
impact of H2S on acute liver failure in mice induced by
Gal and LPS.
Methods
Mice were challenged with saline or combination of Gal
and LPS intraperitoneally, then divided into two groups:
one group breathed air alone, and another breathed H2S
(80 ppm) for 6h followed by breathing air.
Results
Mice that breathed air after Gal/LPS challenge showed
poor survival rate (13%) and marked increase of alanine
aminotransferase (ALT) and aspartate aminotransferase
(AST) in plasma. On the other hand, H2S inhalation for
6h after challenge markedly improved survival (60%, p <
0.05) and suppressed Gal/LPS-induced elevation of ALT
and AST levels in plasma. Inhaled H2S suppressed TNFa
in plasma at 1h after Gal/LPS challenge. Mice that
breathed air after Gal/LPS challenge exhibited activation
of caspase 3, 8, and 9 in the liver, whereas H2S breathing
inhibited activation of caspase 3, 8, and 9, suggesting
inhaled H2S after Gal/LPS challenge suppressed both
extrinsic and intrinsic pathways of caspase-dependent
apoptosis in the liver. Gal/LPS challenge increased phos-
phorylated STAT3 transcription factor. H2S inhalation
after Gal/LPS challenge further augmented phosphoryla-
tion of STAT3 compared to air alone. The protective
effects of H2S inhalation after Gal/LPS challenge were
associated with upregulation of gene expression of anti-
inflammatory IL-10, which stimulates STAT3 phosphory-
lation, in the liver. These results suggest that inhaled H2S
contributes to survival of mice in acute liver failure at
least in part through activation of IL-10/STAT3 pathway.
Conclusions
These results suggest that H2S shows hepatoprotective
effects against acute liver failure at least in part by inhi-
bition of caspase activation and by augmentation of
IL-10/STAT3 signaling pathway in the liver.
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